Deepak Nitrite Limited — Q2 FY26 earnings call

Call held 14 Nov 2025

Management summary

Deepak Nitrite reported a resilient sequential performance in Q2 FY26, driven by strong throughput and efficiency in the Phenolics segment despite a challenging global environment. While the Advanced Intermediates segment struggled with realization pressure from Chinese dumping and tariff uncertainties, the company is pivoting toward high-value downstream products and massive capacity expansion. Management is betting heavily on India's first integrated polycarbonate project and upstream integration in Nitric Acid to drive long-term value.

Highlights

  • Consolidated Revenue stood at ₹1,922 crores, a marginal sequential increase from ₹1,914 crores in Q1 FY26.

  • Consolidated EBITDA grew 5% QoQ to ₹224 crores, with margins expanding 100bps to 12%.

  • PAT for the quarter reached ₹119 crores, up 6% on a sequential basis.

  • Phenolics segment delivered strong performance with 23% sequential EBIT growth to ₹145 crores.

  • Advanced Intermediates (AI) segment faced severe headwinds, with EBIT margins dropping to 4% due to Chinese dumping and U.S. tariffs.

  • Management reaffirmed a massive ₹9,000 crore total CAPEX outlay for the next 3 years, including the integrated polycarbonate project.

  • Commissioned a new hydrogenation asset at Deepak Chem Tech with an investment of ₹118 crores.

  • Domestic to export revenue mix stood at 86:14 for the quarter.

Concerns

  • Chinese Dumping

Key financials

  1. Revenue ₹1,922 Cr +0.4%QoQ
  2. EBITDA ₹224 Cr +5%QoQ
  3. EBITDA Margin 12%
  4. PAT ₹119 Cr +6%QoQ
  5. ROCE 14%
  6. Debt-to-Equity 0.21

What they filed

Q1 FY27: revenue up 31.9%, net profit up 116.7% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue605 552 654 612 616 +2%694 +26%718 +10%807 +32%
EBITDA75 42 78 60 47 −37%45 +7%73 −6%110 +83%
Net profit142 17 54 30 112 −21%8 −53%39 −28%65 +117%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

Share of Revenue
₹1,921 Cr Total
  • Deepak Phenolics ₹1,333 Cr 69.4%
  • Advanced Intermediates ₹588 Cr 30.6%

Guidance & targets

Capex

  • Total Project Outlay Capex · next 3 years · High confidence ₹9,000 crores
    Because the total outlay is around INR 9,000 crore. So, INR 3,000 crore, INR 3,500 crore this year and then INR 4,000 crore next year.

    — Sanjay Upadhyay, Director (Finance) & Group CFO

  • Annual Capex Guidance Capex · FY26 · High confidence ₹1,500 crores
    More or less same [referring to INR 1,500 crore guidance].

    — Sanjay Upadhyay, Director (Finance) & Group CFO

Capacity

  • Polycarbonate Project Commissioning Capacity · Q4 FY28 · Medium confidence March 2028
    So commissioning, we had mentioned earlier, it will be in the month of January to March 2028 quarter.

    — Sanjay Upadhyay, Director (Finance) & Group CFO

Revenue

  • New Product Ramp-up Revenue · mid Q3 FY27 · Medium confidence High operating rates
    But then high operating rates will be from, I would say, mid Q3 onwards, which will then arrive at the end of December or December onwards.

    — Maulik Mehta, Executive Director & CEO

Risks & concerns

  • Chinese Dumping

    high

    Significant dumping observed in Sodium Nitrite, DASDA, and nitro aromatics, impacting AI segment realizations.

    Both acknowledged

  • U.S. Tariffs and Geopolitical Uncertainty

    medium

    Anticipation of new tariffs creates uncertainty in customer buying patterns, particularly for agrochemical intermediates.

    Management acknowledged

  • Raw Material Price Volatility

    medium

    Concerns over Propylene and Russian oil sanctions impacting feedstock costs; management believes short-term indices don't reflect actual consumption prices.

    Analyst downplayed

Areas of evasion (1)

  • Specific volume vs price split for the AI segment was avoided as management claimed the 'answer won't make sense' due to mix shifts.

Q&A highlights

3 direct
Advanced Intermediates Volume Erosion Direct
In the second quarter, regardless of the peak volumes, the volumes that we sent were essentially 0 or close to 0. And this is because there was an intense, I think, 4 or 5 quarters of inventory destocking.

Explains the severe margin and revenue pressure in the AI segment as a temporary destocking issue rather than a permanent loss of market share.

Asked by Nirav Jimudia

Capex Breakup and Capitalization Direct
So I think 95% of this [INR 2,000 crore] would not have anything to do with polycarbonates or phenol. So Nitration, hydrogenation and fluorination in Dahej, this would be over Nitric Acid in Nandesari.

Clarifies that current near-term commissioning projects are focused on specialty chemicals and upstream integration, not the long-dated polycarbonate project.

Asked by Arun Prasath

New Product Pipeline in AI Direct
I'm delighted to share that I think we have started production of 7 new products in just Q2 itself... All of these will be done in existing assets themselves.

Highlights the company's ability to sweat existing assets for new, higher-margin molecules in life sciences and effect chemicals without significant new CAPEX.

Asked by Abhijit Akella

2 min read 5 chapters

Detailed narrative

Phenolics Efficiency Offsets Market Headwinds

The Phenolics business remains the company's bedrock, contributing ₹1,333 crores to revenue in Q2. Despite a challenging pricing environment, the segment achieved a 23% sequential improvement in EBIT, aided by record quarterly production and sales of Isopropyl Alcohol (IPA). Management attributed this to higher throughput and favorable product mix, even as they navigated a 'very hot summer' in Dahej which typically impacts continuous plant efficiency.

Advanced Intermediates Navigating a 'Perfect Storm'

The AI segment faced a difficult quarter with revenue dipping to ₹588 crores and EBIT margins compressing to 4%. This was driven by a combination of intense inventory destocking by global agrochemical majors and aggressive dumping from China in products like Sodium Nitrite and DASDA. Management noted that volumes for some key intermediates were 'essentially 0' in Q2, but they expect a recovery in H2 as customers resume production and inventory levels normalize.

Massive ₹9,000 Crore CAPEX Roadmap

Deepak Nitrite is embarking on a transformative investment cycle with a total outlay of ₹9,000 crores over the next three years. This includes ₹3,000 crores in the current year, followed by ₹3,500 crores and ₹4,000 crores in subsequent years. The centerpiece is India's first integrated polycarbonate project, which is on track for a March 2028 commissioning. The company is utilizing a 'second-mover advantage' by acquiring proven assets and technology, which management claims will result in significantly lower capital costs compared to a greenfield project.

Strategic Pivot to Specialty and Downstream

The company is aggressively moving up the value chain, launching 7 new products in Q2 across life sciences and effect chemicals. These products are being manufactured using existing assets, requiring minimal incremental CAPEX. Furthermore, the new ₹100 crore R&D center at Savli is expected to serve as an innovation hub for developing complex chemistries and supporting CDMO/CMO partnerships, reinforcing the 'Deepak' brand globally.

Upstream Integration to De-risk Supply Chain

A key strategic focus is backward integration into Nitric Acid, with new plants in Nandesari expected to be commissioned shortly. This will provide a captive supply for the company's expanding nitration and hydrogenation capacities. Management emphasized that these plants will be pushed to their limits to maximize margins, as captive consumption offers better returns than merchant sales. Additionally, ammonia storage capacity has been increased 15x to 15 days of consumption, providing a buffer against price volatility and supply disruptions.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Chemicals earnings calls